Connor Dennis

Connor Dennis is a seasoned professional in CMC Technical Writing and regulatory operations, currently serving as Director at PTC Therapeutics, Inc., where responsibilities include leading the preparation and strategy for regulatory dossiers related to global CMC submissions for rare pediatric diseases. Prior experience encompasses positions at Cardinal Health, where Connor managed a team in CMC Regulatory Operations and developed analytics for regulatory affairs, and roles at Orbis Biosciences focusing on formulation development. Connor's academic background includes a PhD in Bioengineering and a B.S. in Chemical and Petroleum Engineering from the University of Kansas.